All Resources

Defining a COVID-19 vaccine primary series

Description

This table defines what is considered fully vaccinated for COVID-19 in the province of Alberta, and can be consulted when determining proof of vaccination.

Tags

Defining fully immunized – COVID-19

Description

This table defines what is considered fully vaccinated for COVID-19 in the province of Alberta, and can be consulted when determining proof of vaccination.

Tags

Canadian vaccine injury support program (VISP)

Description

Explains the purpose and eligibility criteria of the Vaccine Injury Support Program. The purpose of the program is to ensure that all people in Canada who have experienced a serious and permanent... More ≫

Description

Explains the purpose and eligibility criteria of the Vaccine Injury Support Program. The purpose of the program is to ensure that all people in Canada who have experienced a serious and permanent injury as a result of receiving a Health Canada authorized vaccine, administered in Canada on or after December 8, 2020, have fair and timely access to financial support.

Tags

Pneumococcal Polysaccharide 23-Valent immunization program

Description

As of January 1, 2019, pharmacists will be able to provide routine Pneumococcal Polysaccharide 23 –Valent vaccine (Pneumo-P 23) to eligible adults 65 years of age and older. This fact sheet... More ≫

Description

As of January 1, 2019, pharmacists will be able to provide routine Pneumococcal Polysaccharide 23 –Valent vaccine (Pneumo-P 23) to eligible adults 65 years of age and older. This fact sheet outlines the eligibility criteria for the vaccine and reporting requirements for pharmacists. Included is decision tree to assist pharmacists in determining client eligibility.

Tags

Measles vaccine uptake for children aged 12 to 24 months

Description

exams the impact of neighborhood income on the timeliness of first MMR (Measles, Mumps and Rubella)/MMRV(Measles, Mumps, Rubella and Varicella) dose among children born in Alberta between 2006 and... More ≫

Description

exams the impact of neighborhood income on the timeliness of first MMR (Measles, Mumps and Rubella)/MMRV(Measles, Mumps, Rubella and Varicella) dose among children born in Alberta between 2006 and 2012 and followed until February 2015.

Tags